Fen‐Er Chen
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Organic Chemistry top 0.2%
- Catalytic C–H Functionalization Methods
- Asymmetric Synthesis and Catalysis
- Sulfur-Based Synthesis Techniques
Papers in
-
- Asymmetric Synthesis and Catalysis 72
- Catalytic C–H Functionalization Methods 72
-
- Chemical Synthesis and Analysis 61
- Co-authors
- Erik De Clercq (92 shared papers)Christophe Pannecouque (91 shared papers)Chunlin Zhuang (27 shared papers)Jian Huang (6 shared papers)Wenxue Chen (29 shared papers)Jan Balzarini (29 shared papers)Suxi Wang (7 shared papers)Fangjun Xiong (20 shared papers)
In The Last Decade
Fen‐Er Chen
484 papers receiving 7.8k citations
Fen‐Er Chen's Hit Papers
Peers
Comparison fields: 5 of 132
- Virology 1.0k
- Organic Chemistry 4.8k
- Infectious Diseases 1.5k
- Process Chemistry and Technology 210
- Inorganic Chemistry 1000
Countries citing papers authored by Fen‐Er Chen
This map shows the geographic impact of Fen‐Er Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fen‐Er Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fen‐Er Chen more than expected).
Fields of papers citing papers by Fen‐Er Chen
This network shows the impact of papers produced by Fen‐Er Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fen‐Er Chen. The network helps show where Fen‐Er Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Fen‐Er Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 515 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 285 | |
| 2 | 2005 | 225 | |
| 3 | Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years Hit paper breakdown → | 2022 | 224 |
| 4 | 2021 | 145 | |
| 5 | 2010 | 131 | |
| 6 | 2021 | 123 | |
| 7 | 2019 | 105 | |
| 8 | 2007 | 105 | |
| 9 | 2017 | 87 | |
| 10 | 2020 | 86 | |
| 11 | 2020 | 83 | |
| 12 | 2019 | 76 | |
| 13 | 2010 | 76 | |
| 14 | 2022 | 71 | |
| 15 | 2017 | 62 | |
| 16 | 2023 | 61 | |
| 17 | 2009 | 60 | |
| 18 | 2021 | 60 | |
| 19 | 2021 | 60 | |
| 20 | 2012 | 57 |
About Fen‐Er Chen
Fen‐Er Chen is a scholar working on Organic Chemistry, Molecular Biology, Infectious Diseases, Virology and Inorganic Chemistry, having authored 515 papers that have together received 7.9k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (115 papers), HIV Research and Treatment (80 papers), Asymmetric Synthesis and Catalysis (72 papers), Catalytic C–H Functionalization Methods (72 papers), Chemical Synthesis and Analysis (61 papers), Asymmetric Hydrogenation and Catalysis (59 papers), Pneumocystis jirovecii pneumonia detection and treatment (52 papers) and Innovative Microfluidic and Catalytic Techniques Innovation (48 papers). The work is most often cited by research in Virology (1.0k citations), Organic Chemistry (4.8k citations), Infectious Diseases (1.5k citations), Process Chemistry and Technology (210 citations) and Inorganic Chemistry (1000 citations). Fen‐Er Chen has collaborated with scholars based in China, Belgium and Singapore. Frequent co-authors include Erik De Clercq, Christophe Pannecouque, Chunlin Zhuang, Jian Huang, Wenxue Chen, Jan Balzarini, Suxi Wang, Fangjun Xiong, Qiuqin He and Minjie Liu. Their work appears in journals such as European Journal of Medicinal Chemistry, Chinese Chemical Letters, Organic Letters, Green Synthesis and Catalysis and The Journal of Organic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.